Is Jianmin Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Jianmin Pharmaceutical pays dividends. Last time was Friday 26th of April 2024 where the investors holding the stock on Friday 26th of April 2024 were paid CNY1.2 per share. Over the last 17 times between 2004 and 2024, Jianmin Pharmaceutical has paid CNY6.412 with an average of CNY0.38 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Jianmin Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY17.96, you would have made a profit of CNY24.51 per share or 136.47%
Yes, the average daily trading liquidity for Jianmin Pharmaceutical is CNY1.79 million. You should therefore be able to get in and out of your positions relatively fast.
Jianmin Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.53, the company's ability to pay off the debt is good. Jianmin Pharmaceutical has a good net profit margin of 12.54% and should have high tolerances against inflation.
We have calculated the inflation risk for Jianmin Pharmaceutical to be low [0.25 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.